These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 33663163)

  • 21. Potassium is a key signal in host-microbiome dysbiosis in periodontitis.
    Yost S; Duran-Pinedo AE; Krishnan K; Frias-Lopez J
    PLoS Pathog; 2017 Jun; 13(6):e1006457. PubMed ID: 28632755
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Research progress of polymicrobial synergy and dysbiosis in periodontitis].
    Zhao CZ; Chen Z; Li MY
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2021 Mar; 56(3):301-305. PubMed ID: 33663163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the microbiota in periodontal disease.
    Curtis MA; Diaz PI; Van Dyke TE
    Periodontol 2000; 2020 Jun; 83(1):14-25. PubMed ID: 32385883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymicrobial communities in periodontal disease: Their quasi-organismal nature and dialogue with the host.
    Hajishengallis G; Lamont RJ
    Periodontol 2000; 2021 Jun; 86(1):210-230. PubMed ID: 33690950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Nexus Between Periodontal Inflammation and Dysbiosis.
    Van Dyke TE; Bartold PM; Reynolds EC
    Front Immunol; 2020; 11():511. PubMed ID: 32296429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology.
    Hajishengallis G; Lamont RJ
    Mol Oral Microbiol; 2012 Dec; 27(6):409-19. PubMed ID: 23134607
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the microbial components of periodontal diseases and periodontal treatment-induced microbiological shifts.
    Fragkioudakis I; Riggio MP; Apatzidou DA
    J Med Microbiol; 2021 Jan; 70(1):. PubMed ID: 33295858
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The oral microbiota: dynamic communities and host interactions.
    Lamont RJ; Koo H; Hajishengallis G
    Nat Rev Microbiol; 2018 Dec; 16(12):745-759. PubMed ID: 30301974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oral polymicrobial communities: Assembly, function, and impact on diseases.
    Hajishengallis G; Lamont RJ; Koo H
    Cell Host Microbe; 2023 Apr; 31(4):528-538. PubMed ID: 36933557
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Polymicrobial Interactions of Oral Microbiota: a Historical Review and Current Perspective.
    Zhang M; Whiteley M; Lewin GR
    mBio; 2022 Jun; 13(3):e0023522. PubMed ID: 35491817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymicrobial synergy and dysbiosis: An overview.
    Shaikh HFM; Patil SH; Pangam TS; Rathod KV
    J Indian Soc Periodontol; 2018; 22(2):101-106. PubMed ID: 29769762
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral Bacteria and Intestinal Dysbiosis in Colorectal Cancer.
    Koliarakis I; Messaritakis I; Nikolouzakis TK; Hamilos G; Souglakos J; Tsiaoussis J
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31450675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Humanized Mouse Models for the Study of Periodontitis: An Opportunity to Elucidate Unresolved Aspects of Its Immunopathogenesis and Analyze New Immunotherapeutic Strategies.
    Rojas C; García MP; Polanco AF; González-Osuna L; Sierra-Cristancho A; Melgar-Rodríguez S; Cafferata EA; Vernal R
    Front Immunol; 2021; 12():663328. PubMed ID: 34220811
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Therapeutic and Metagenomic Potential of the Biomolecular Therapies against Periodontitis and the Oral Microbiome: Current Evidence and Future Perspectives.
    Santonocito S; Ferlito S; Polizzi A; Ronsivalle V; Sclafani R; Valletta A; Lo Giudice A; Cavalcanti R; Spagnuolo G; Isola G
    Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430182
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gut microbial dysbiosis and inflammation: Impact on periodontal health.
    Zhao Y; Liu Y; Jia L
    J Periodontal Res; 2024 Jul; ():. PubMed ID: 38991951
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral microbiota-induced periodontitis: a new risk factor of metabolic diseases.
    Minty M; Canceil T; Serino M; Burcelin R; Tercé F; Blasco-Baque V
    Rev Endocr Metab Disord; 2019 Dec; 20(4):449-459. PubMed ID: 31741266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolism of periodontal pathobionts: Their regulatory roles in the dysbiotic microbiota.
    Ding J; Zhao C; Gao L
    Mol Oral Microbiol; 2023 Jun; 38(3):181-188. PubMed ID: 36811357
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current understanding of periodontal disease pathogenesis and targets for host-modulation therapy.
    Hajishengallis G; Chavakis T; Lambris JD
    Periodontol 2000; 2020 Oct; 84(1):14-34. PubMed ID: 32844416
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.